Article Information
History
- May 8, 2025.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Caihua Lianga,*,
- Erica L. Chilsona,
- Joanne Wua,
- Scott P. Kellya,
- Qing Liua,
- Kathleen L. Doolinga,
- Maria Maddalena Linob,
- Joseph A. Lewnardc,
- Bradford D. Gessnera and
- Elizabeth Begierd
- aPfizer Inc., New York/Collegeville, USA
- bPfizer S.r.l., Rome/Latina, Italy
- cSchool of Public Health, University of California, Berkeley, USA
- dPfizer Healthcare Ireland, Dublin, Ireland
- ↵*Corresponding author: Pfizer Inc., 66 Hudson Boulevard East, New York, NY 10001-2192, USA; E-mail: Caihua.Liang{at}pfizer.com (C. Liang).





